The bottom line: Other experts in the field tell Axios they agree there’s an urgent need to focus on the AMR Challenge’s “one health” approach to target humans, animals and the environment.
- Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases, tells Axios there are two main arms to combating AMR: preventing AMR from developing via good stewardship of current antibiotics and other methods, and “developing a robust pipeline of new antibiotics.”
- Greg Frank, director of the advocacy coalition Working to Fight AMR, agrees, adding that it’s important for President Trump and Congress to “lead this fight — by incentivizing the development of new, life-saving antibiotics” before more drug companies go out of business.
- Laxminarayan, who also sits on the U.S. Presidential Advisory Council on Combating Antibiotic Resistant Bacteria, says “if you’re going to solve this, it has to be [through the] one health issue — for humans and animals together.”
More from Axios here.